Related Experiment Video
Updated: Jul 16, 2025
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.3K
Nitric oxide in kidney transplantation.
1Department of Pharmacology and Toxicology, School of Pharmacy, College of Health Sciences, University of Ghana, Legon, Accra, Ghana; Accra College of Medicine, Magnolia St, JVX5+FX9, East Legon, Accra, Ghana.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|September 18, 2023
Summary
Nitric oxide (NO) shows promise in preventing kidney transplant complications like ischemia-reperfusion injury (IRI). Administering NO can protect kidney grafts from damage and rejection, improving patient outcomes.
Area of Science:
- Nephrology and Transplant Surgery
- Biomedical Science
- Biochemistry
Background:
- Kidney transplantation offers superior outcomes to dialysis but is threatened by ischemia-reperfusion injury (IRI).
- IRI leads to graft dysfunction and recipient mortality post-transplantation.
- Endogenous nitric oxide (NO) dysregulation is linked to IRI in kidney transplantation.
Purpose of the Study:
- To review the role of nitric oxide (NO) in mitigating kidney transplant ischemia-reperfusion injury (IRI).
- To discuss endogenous and exogenous sources of NO and their protective mechanisms.
- To highlight NO's potential in preventing acute and chronic graft rejection.
Main Methods:
- Review of experimental and clinical studies on NO in kidney transplantation.
- Analysis of signaling pathways involved in NO-mediated protection against IRI.
- Examination of NO's effects when administered exogenously or produced endogenously.
Main Results:
- Constitutive nitric oxide synthase (NOS)-derived NO demonstrates protective effects against IRI via multiple signaling pathways.
- Low concentrations of NO in preservation solutions or administration to donor/recipient can mitigate IRI.
- Inducible NOS (iNOS) also shows potential for renal graft protection in isolated studies.
Conclusions:
- Nitric oxide (NO) holds significant clinical promise for reducing ischemia-reperfusion injury (IRI) in kidney transplantation.
- Modulating NO levels, through endogenous or exogenous means, can prevent graft rejection and improve long-term transplant success.
- Further research into NO's protective mechanisms is warranted to optimize its clinical application in transplantation.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
36
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
01:28Nitric Oxide Signaling Pathway
5.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
01:16Kidney Transplant III: Nursing Management
39
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
39
01:28Kidney Transplant I: Introduction
28
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
28
01:29Acute Kidney Injury II: Pathophysiology
26
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
26
01:22Acute Kidney Injury I: Introduction
28
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
28